Texas Capital Bank Wealth Management Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,000
Closed -$295K 191
2024
Q3
$295K Hold
20,000
0.03% 155
2024
Q2
$277K Hold
20,000
0.03% 161
2024
Q1
$314K Buy
+20,000
New +$309K 0.03% 155
2023
Q4
Sell
-10,000
Closed -$123K 216
2023
Q3
$123K Buy
+10,000
New +$149K 0.02% 193

Other funds holding NEO

Texas Capital Bank Wealth Management Services's NEO Position: Q4 2024 in Review

Texas Capital Bank Wealth Management Services sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 20,000 shares — an estimated $295K sold.

Texas Capital Bank Wealth Management Services first reported a position in NEO in Q3 2023 and held it in 4 quarters. The position peaked at $314K in Q1 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Texas Capital Bank Wealth Management Services reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Texas Capital Bank Wealth Management Services sold 20,000 NeoGenomics shares in Q4 2024, an estimated $295K.
  • Texas Capital Bank Wealth Management Services first reported a position in NeoGenomics in Q3 2023 and held it in 4 quarters.
  • Texas Capital Bank Wealth Management Services's NeoGenomics position peaked at $314K in Q1 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q4 2024, filed 13 Feb 2025.